Atlas Trials

Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment

Clinical trial NCT00909831 · COMPLETED

Trial details

NCT number
NCT00909831
Sponsor
Abramson Cancer Center at Penn Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Unspecified Adult Solid Tumor, Protocol Specific
Start date
2008-10-01
Primary completion
2012-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.